Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma (Q40232283)

14 July 2018

title

Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma (English)

1 reference

14 July 2018

1 reference

11

1 reference

14 July 2018

Richard Houlston

18

1 reference

14 July 2018

Charlotte Pawlyn

object named as

Charlotte Pawlyn

6

0 references

Kari Hemminki

17

object named as

Kari Hemminki

1 reference

14 July 2018

Gareth J Morgan

21

0 references

Bart Barlogie

19

object named as

Bart Barlogie

1 reference

14 July 2018

10

Shmuel Yaccoby

1 reference

14 July 2018

13

Maurizio Zangari

1 reference

14 July 2018

16

Hartmut Goldschmidt

1 reference

14 July 2018

author name string

Leo Rasche

1

1 reference

14 July 2018

Edgardo Angtuaco

2

1 reference

14 July 2018

James E McDonald

3

1 reference

14 July 2018

Amy Buros

4

1 reference

14 July 2018

Caleb Stein

5

1 reference

14 July 2018

Sharmilan Thanendrarajan

7

1 reference

14 July 2018

Carolina Schinke

8

1 reference

14 July 2018

Rohan Samant

9

1 reference

14 July 2018

Joshua Epstein

12

1 reference

14 July 2018

Tobias Meissner

15

1 reference

14 July 2018

Faith E Davies

20

1 reference

14 July 2018

Niels Weinhold

22

1 reference

14 July 2018

language of work or name

English

0 references

publication date

21 April 2017

1 reference

14 July 2018

published in

Blood

1 reference

14 July 2018

volume

130

1 reference

14 July 2018

issue

1

1 reference

14 July 2018

page(s)

30-34

1 reference

14 July 2018

[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expression

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

The Role of Imaging in the Treatment of Patients With Multiple Myeloma in 2016.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

11C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

Clinical value of molecular subtyping multiple myeloma using gene expression profiling

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

Oncogene pathway activation in mammary tumors dictates FDG-PET uptake

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging "early myeloma".

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

The molecular classification of multiple myeloma

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

Cellular release of [18F]2-fluoro-2-deoxyglucose as a function of the glucose-6-phosphatase enzyme system.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5501152

High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28432222

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28432222

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Relationship between bone marrow cellularity and apparent diffusion coefficient

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28432222

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1182/BLOOD-2017-03-774422

1 reference

14 July 2018

PMC publication ID

5501152

1 reference

14 July 2018

PubMed publication ID

28432222

1 reference

14 July 2018